Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

31. March 2020 - 0:00 (CEST)

Epigenomics AG successfully completes capital increase

Read more

30. March 2020 - 0:00 (CEST)

Epigenomics AG decides to increase share capital by way of private placement

Read more

28. February 2020 - 0:00 (CEST)

Centers for Medicare & Medicaid Services open NCD review process for Epi proColon

Read more

Press releases

31. August 2020

Epigenomics AG: CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible

Read more

13. August 2020

Epigenomics AG presents operational highlights and reports financial results for first six months of 2020

Read more

10. August 2020

New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening

Read more